Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial
Branch-Elliman et al., PLOS ONE, doi:10.1371/journal.pone.0263591
https://c19early.org/branchelliman.html